Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
VZLA
4176
Vizsla Silver
VZLA
$1.28B
| $235K | ﹤0.01% |
+42,934
| New | +$202K |
2025 Q4
0 quarters
|
|
|
OMDA
4177
Omada Health Inc
OMDA
$1.25B
| $234K | ﹤0.01% |
14,850
+1,888
| +15% | +$38.3K |
2025 Q2
2 quarters
|
|
4178
Gran Tierra Energy
GTE
$369M
| $234K | ﹤0.01% |
55,239
| – | – |
2022 Q2
14 quarters
|
|
4179
908 Devices
MASS
$525M
| $234K | ﹤0.01% |
44,528
+5,943
| +15% | +$41.5K |
2022 Q1
15 quarters
|
|
4180
Priority Technology Holdings
PRTH
$642M
| $233K | ﹤0.01% |
42,703
+7,013
| +20% | +$43.4K |
2019 Q2
26 quarters
|
|
|
TSSI
4181
TSS Inc
TSSI
$289M
| $233K | ﹤0.01% |
32,917
+6,621
| +25% | +$85.6K |
2025 Q2
2 quarters
|
|
4182
State Street SPDR S&P China ETF
GXC
$448M
| $232K | ﹤0.01% |
2,400
| – | – |
2020 Q4
20 quarters
|
|
|
SBDS
4183
DELISTED
Solo Brands Inc
SBDS
| $232K | ﹤0.01% |
38,297
| – | – |
2025 Q3
1 quarter
|
|
4184
Pioneer Bancorp
PBFS
$430M
| $231K | ﹤0.01% |
17,139
-1,013
| -6% | -$13.6K |
2022 Q1
15 quarters
|
|
4185
Outdoor Holding Co
POWW
$266M
| $231K | ﹤0.01% |
135,012
+12,952
| +11% | +$22.3K |
2021 Q2
18 quarters
|
|
|
SEG
4186
Seaport Entertainment Group
SEG
$287M
| $231K | ﹤0.01% |
11,666
+1,075
| +10% | +$24.1K |
2024 Q3
5 quarters
|
|
|
GPMT
4187
Granite Point Mortgage Trust
GPMT
$36.7M
| $230K | ﹤0.01% |
95,931
+50,747
| +112% | +$136K |
2017 Q3
33 quarters
|
|
|
GETY
4188
DELISTED
GETTY IMAGES HLDGS INC A
GETY
| $230K | ﹤0.01% |
171,777
+16,347
| +11% | +$28.1K |
2024 Q2
6 quarters
|
|
4189
X4 Pharmaceuticals
XFOR
$281M
| $230K | ﹤0.01% |
+57,500
| New | +$209K |
2025 Q4
0 quarters
|
|
4190
Brookfield Infrastructure Partners
BIP
$16.8B
| $229K | ﹤0.01% |
6,599
+6,300
| +2,107% | +$219K |
2013 Q4
48 quarters
|
|
4191
Icahn Enterprises
IEP
$4.74B
| $228K | ﹤0.01% |
30,205
+637
| +2% | +$5.13K |
2020 Q4
20 quarters
|
|
|
FFAI
4192
Faraday Future Intelligent Electric
FFAI
$7.54M
| $228K | ﹤0.01% |
1,488
+122
| +9% | +$22.7K |
2025 Q2
2 quarters
|
|
4193
InfuSystem Holdings
INFU
$262M
| $227K | ﹤0.01% |
25,312
+13,207
| +109% | +$126K |
2023 Q2
10 quarters
|
|
4194
HighPeak Energy
HPK
$993M
| $227K | ﹤0.01% |
47,888
-15,003
| -24% | -$90.2K |
2022 Q1
15 quarters
|
|
4195
Canadian Solar
CSIQ
$760M
| $225K | ﹤0.01% |
9,471
-6,127
| -39% | -$134K |
2021 Q3
17 quarters
|
|
|
LAR
4196
Lithium Argentina AG
LAR
$901M
| $224K | ﹤0.01% |
40,215
-38,944
| -49% | -$185K |
2023 Q4
8 quarters
|
|
4197
Bakkt Inc
BKKT
$349M
| $224K | ﹤0.01% |
22,345
+6,774
| +44% | +$150K |
2024 Q3
5 quarters
|
|
4198
CALL
Sumitomo Mitsui Financial Group, Inc American Depositary Shares (each representing 1.2 shares of Common Stock)
SMFG
$161B
| $224K | ﹤0.01% |
+11,600
| New | +$201K |
2025 Q4
0 quarters
|
|
4199
Lexicon Pharmaceuticals
LXRX
$810M
| $224K | ﹤0.01% |
194,743
+162,881
| +511% | +$224K |
2013 Q2
50 quarters
|
|
4200
Virgin Galactic
SPCE
$459M
| $222K | ﹤0.01% |
69,229
+68,466
| +8,973% | +$258K |
2022 Q1
15 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.